Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josef Mautner

Showing results (11-20 of 73) with videos related to

Pageof 8
Sort By:
International Journal of Cancer|February 11, 2005
Tumor-specific CD4+ T cells from a patient with renal cell carcinoma recognize diverse shared antigensJosef Mautner, Elizabeth M Jaffee, Drew M Pardoll
Frontiers in Oncology|March 13, 2019
Progress in EBV VaccinesDwain G van Zyl, Josef Mautner, Henri-Jacques Delecluse
European Journal of Immunology|December 16, 2014
Polyubiquitination of lysine-48 is an essential but indirect signal for MHC class I antigen processingBenjamin M Fiebiger, Heike Pfister, Uta Behrends, et al.
Seminars in Cancer Biology|October 22, 2008
Contribution of viral recombinants to the study of the immune response against the Epstein-Barr virusHenri-Jacques Delecluse, Regina Feederle, Uta Behrends, et al.
European Journal of Immunology|September 5, 2012
Mature proteins derived from Epstein-Barr virus fail to feed into the MHC class I antigenic poolBenjamin M Fiebiger, Andreas Moosmann, Uta Behrends, et al.
Frontiers in Immunology|December 5, 2015
A Diverse Repertoire of CD4 T Cells Targets the Immediate-Early 1 Protein of Human CytomegalovirusStefanie Ameres, Xiaoling Liang, Martina Wiesner, et al.
The Journal of General Virology|February 22, 2005
Epstein-Barr virus latent membrane protein 2A mimics B-cell receptor-dependent virus reactivationEveline Schaadt, Barbara Baier, Josef Mautner, et al.
Journal of Virology|February 15, 2008
Standardized and highly efficient expansion of Epstein-Barr virus-specific CD4+ T cells by using virus-like particlesDinesh Adhikary, Uta Behrends, Regina Feederle, et al.
Molecular Immunology|January 12, 2018
Immunization with recombinant FliD confers protection against Helicobacter pylori infection in miceAmir Ghasemi, Nazanin Mohammad, Josef Mautner, et al.
Vaccine|September 20, 2015
Simultaneous immunization of mice with Omp31 and TF provides protection against Brucella melitensis infectionAmir Ghasemi, Mahmood Jeddi-Tehrani, Josef Mautner, et al.
Pageof 8

Showing results (11-20 of 73) with videos related to

Sort By:
Pageof 8
International Journal of Cancer|February 11, 2005
Tumor-specific CD4+ T cells from a patient with renal cell carcinoma recognize diverse shared antigensJosef Mautner, Elizabeth M Jaffee, Drew M Pardoll
Frontiers in Oncology|March 13, 2019
Progress in EBV VaccinesDwain G van Zyl, Josef Mautner, Henri-Jacques Delecluse
European Journal of Immunology|December 16, 2014
Polyubiquitination of lysine-48 is an essential but indirect signal for MHC class I antigen processingBenjamin M Fiebiger, Heike Pfister, Uta Behrends, et al.
Seminars in Cancer Biology|October 22, 2008
Contribution of viral recombinants to the study of the immune response against the Epstein-Barr virusHenri-Jacques Delecluse, Regina Feederle, Uta Behrends, et al.
European Journal of Immunology|September 5, 2012
Mature proteins derived from Epstein-Barr virus fail to feed into the MHC class I antigenic poolBenjamin M Fiebiger, Andreas Moosmann, Uta Behrends, et al.
Frontiers in Immunology|December 5, 2015
A Diverse Repertoire of CD4 T Cells Targets the Immediate-Early 1 Protein of Human CytomegalovirusStefanie Ameres, Xiaoling Liang, Martina Wiesner, et al.
The Journal of General Virology|February 22, 2005
Epstein-Barr virus latent membrane protein 2A mimics B-cell receptor-dependent virus reactivationEveline Schaadt, Barbara Baier, Josef Mautner, et al.
Journal of Virology|February 15, 2008
Standardized and highly efficient expansion of Epstein-Barr virus-specific CD4+ T cells by using virus-like particlesDinesh Adhikary, Uta Behrends, Regina Feederle, et al.
Molecular Immunology|January 12, 2018
Immunization with recombinant FliD confers protection against Helicobacter pylori infection in miceAmir Ghasemi, Nazanin Mohammad, Josef Mautner, et al.
Vaccine|September 20, 2015
Simultaneous immunization of mice with Omp31 and TF provides protection against Brucella melitensis infectionAmir Ghasemi, Mahmood Jeddi-Tehrani, Josef Mautner, et al.
Pageof 8